1·Our laboratory data are used to develop this model.
我们用试验数据来得到这个模型。
2·The suitability of the model was analyzed and verified with laboratory data.
通过试验验证，分析了模型的适用性。
3·Methods Clinical and laboratory data from 28 patients were retrospectively analyzed.
方法回顾性分析28例妊娠重肝患者的临床表现及实验室资料。
4·Methods The clinical and laboratory data of 2 case of AIHA were studied retrospectively.
方法对2例aiha的临床及实验室资料进行了回顾性分析。
5·Methods Clinical and laboratory data of 56 patients with RP were analyzed retrospectively.
方法回顾性分析56例复发性多软骨炎患者的临床及辅助检查资料。
6·Methods Clinical and laboratory data of 85 patients with PBC were retrospectively analyzed.
方法观察85例PBC患者的临床表现，并分析有关实验室检查资料。
7·Clinic and laboratory data shows limit resource of cell lines can't satisfy the needs of study.
临床及实验资料说明现有的肝癌细胞系资源还远远不能满足研究的需要。
8·The clinical and laboratory data of 105 patients with systemic scleroderma (SSC) were analysed.
对105例系统性硬皮病患者的一般情况、临床表现作了详细分析。
9·Transimssibility analysis of the laboratory data document far less hull motion in the semiactive case .
实验室对传输能力的分析研究数据证明在半活动情况下实体运动要远少的多。
10·Reference laboratory data are scattered and clinical descriptions of rare conditions are hard to locate.
参考实验室数据被散布，稀有的条件的临床的描述难找到。